HC Wainwright & Co. Reiterates Buy on AnaptysBio, Maintains $55 Price Target

AnaptysBio, Inc. -2.80% Post

AnaptysBio, Inc.

ANAB

20.17

20.70

-2.80%

+2.63% Post

HC Wainwright & Co. analyst Emily Bodnar reiterates AnaptysBio (NASDAQ: ANAB) with a Buy and maintains $55 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via